Autism spectrum disorders following in utero exposure to antiepileptic drugs.
Evatt
M L
ML
DeLong
M R
MR
Grant
W B
WB
Cannell
J J
JJ
Tangpricha
V
V
D000927:Anticonvulsants / Q000009:adverse effects*; D001321:Autistic Disorder / Q000139:chemically induced* / Q000378:metabolism* / Q000503:physiopathology; D001921:Brain / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism; D002675:Child, Preschool; D005260:Female; D005843:Geography; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000378:metabolism* / Q000503:physiopathology; D018167:Receptors, Calcitriol / Q000378:metabolism; D014807:Vitamin D / Q000378:metabolism; D014808:Vitamin D Deficiency / Q000139:chemically induced* / Q000378:metabolism* / Q000503:physiopathology
D000927:Anticonvulsants; D018167:Receptors, Calcitriol; D014807:Vitamin D